Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for SUNSHINE PHARMA?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2021–2025
Financial statements are reported in CNY, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from CN¥1.06B in FY2021 to CN¥4.82B in FY2025 (4-year CAGR +46.1%).
- Net income was negative in FY2021, FY2022, FY2024.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (CNY B) | 1.06 | 3.81 | 6.39 | 4.02 | 4.82 |
| YoY | — | 260.4% | 67.4% | -37.1% | 19.8% |
| Net Income (CNY B) | -1.75 | -1.21 | 0.18 | -0.21 | 0.27 |
| YoY | — | — | — | -212.2% | — |
| Operating Cash Flow (CNY B) | -0.99 | 1.16 | 1.32 | 0.50 | 1.16 |
| ROE | — | — | 56.4% | -61.7% | 11.6% |
| Gross Margin | 54.9% | 76.6% | 79.5% | 76.1% | 76.5% |
| Net Margin | -165.5% | -31.7% | 2.9% | -5.2% | 5.7% |
| Debt-to-Assets | 172.3% | 108.2% | 67.0% | 62.6% | 63.8% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
-
Alert
Short-Term Debt CoverageSolvency
Cash CN¥1.48B, short-term debt CN¥3.46B (0.43x)
Interim (2026-06-30) · What is this?
-
Watch
Profit WarningMaterial Events
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
No dividends paid over the trailing 12 months.
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.